These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9238422)

  • 1. [Detection of liver metastases from digestive cancer. Value of alkaline phosphatases, their macromolecular isoenzyme and of ceruloplasmin].
    Piva MT; Sieso V; Lumbroso S; Perney P; Mion H; Blanc
    Ann Biol Clin (Paris); 1997; 55(3):209-14. PubMed ID: 9238422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of hepatic metastasis of digestive cancers. Value of enzyme assays and ultrasonography].
    Molkhou JM; Lacaine F; Houry S; Huguier M
    Presse Med; 1989 Sep; 18(28):1370-4. PubMed ID: 2571989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of serum alkaline phosphatase alpha 1 isoenzyme in the diagnosis of liver metastases. Preliminary results.
    Viot M; Joulin C; Cambon P; Krebs BP; Schneider M; Lalanne CM
    Biomedicine; 1979 Jun; 31(3):74-7. PubMed ID: 486695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary tryrosinemia. 3. Biological evaluation of the tyrosinemic patient. Clinical value of hypoceruloplasminemia and evolution of alkaline phosphatase and lactate dehydrogenase isoenzymes].
    Bélanger L; Bélanger M; Larochelle J; Tremblay M; Aubin G; Saint-Hilaire B
    Pediatrie; 1973; 28(1):23-34. PubMed ID: 4715465
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic metastases. Detection: methodology, application to biological assays].
    Huguier M; Lacaine F; Houry S; Rey C
    Ann Chir; 1985 May; 39(4):275-9. PubMed ID: 2862834
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkaline phosphatase isoenzymes for the diagnosis of metastatic tumors and lymphomas of liver and bone.
    Yorio MA; Sembaj A; Sanz E; Carriazo C; Moreno Barral J
    Medicina (B Aires); 2000; 60(3):311-5. PubMed ID: 11050806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retinol-binding protein, haptoglobin and ceruloplasmin--tumor markers in colorectal cancer?].
    Putzki H; Reichert B; Hinz M
    Z Gesamte Inn Med; 1990 Jan; 45(2):50-2. PubMed ID: 2327134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
    Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
    Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of lactate dehydrogenase (LDH) isoenzymes in the diagnosis of hepatic metastases].
    Plomteux G; Toulet J
    Rev Med Chir Mal Foie; 1971; 46(2):75-80. PubMed ID: 5089127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency].
    Sánchez Navarro MR; Fernández-Conde ME; Blanco Martín S; Samaniego C
    An Med Interna; 2002 Sep; 19(9):449-52. PubMed ID: 12420628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the damage of liver in patients with SARS].
    Guan YJ; Tang XP; Yin CB; Yi ZQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
    Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
    Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and ceruloplasmin; serial studies in viral and alcoholic liver disease.
    Guattery JM; Aroesty S; Wilson H; Rubulis A; Flood MS; Faloon WW
    N Y State J Med; 1981 Oct; 81(11):1603-12. PubMed ID: 6945490
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer.
    Yildirim A; Meral M; Kaynar H; Polat H; Ucar EY
    Med Sci Monit; 2007 Apr; 13(4):CR195-200. PubMed ID: 17392651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total activity and the isoenzyme spectrum of lactate dehydrogenase, creatine kinase and alkaline phosphatase in connective tissue diseases].
    Dovzhanskiĭ SI; Nikiforova NE; Ital'ianskaia IuV; Loginova LA; Iudina VS
    Vestn Dermatol Venerol; 1981 Mar; (3):8-11. PubMed ID: 7257604
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical significance of monitoring alkaline phosphatase level to estimate postoperative liver failure after hepatectomy.
    Osada S; Saji S
    Hepatogastroenterology; 2004; 51(59):1434-8. PubMed ID: 15362770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
    Agbedana EO; Ebesunun MO
    Afr J Med Med Sci; 1998; 27(1-2):65-9. PubMed ID: 10456133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.